A dual GLP-1 and Gcg receptor agonist rescues spatial memory and synaptic plasticity in APP/PS1 transgenic mice

Alzheimer's disease (AD) is a neurodegenerative disease that severely affects the health and lifespan of the elderly worldwide. Recently, the correlation between AD and type 2 diabetes mellitus (T2DM) has received intensive attention, and a promising new anti-AD strategy is the use of anti-diab...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hormones and behavior 2020-02, Vol.118, p.104640-104640, Article 104640
Hauptverfasser: Wang, Zhao-Jun, Han, Yu-Fei, Zhao, Fang, Yang, Guang-Zhao, Yuan, Li, Cai, Hong-Yan, Yang, Jun-Ting, Holscher, Christian, Qi, Jin-Shun, Wu, Mei-Na
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Alzheimer's disease (AD) is a neurodegenerative disease that severely affects the health and lifespan of the elderly worldwide. Recently, the correlation between AD and type 2 diabetes mellitus (T2DM) has received intensive attention, and a promising new anti-AD strategy is the use of anti-diabetic drugs. Oxyntomodulin (Oxm) is a peptide hormone and growth factor that acts on neurons in the hypothalamus. OXM activates glucagon-like peptide 1 (GLP-1) and glucagon (Gcg) receptors, facilitates insulin signaling and has neuroprotective effects against Aβ1–42-induced cytotoxicity in primary hippocampal neurons. Here, we tested the effects of the protease-resistant analogue (D-Ser2)Oxm on spatial memory and synaptic plasticity and the underlying molecular mechanisms in the APP/PS1 transgenic mouse model of AD. The results showed that (D-Ser2)Oxm not only alleviated the impairments of working memory and long-term spatial memory, but also reduced the number of Aβ plaques in the hippocampus, and reversed the suppression of hippocampal synaptic long-term potentiation (LTP). Moreover, (D-Ser2)Oxm administration significantly increased p-PI3K/p-AKT1 expression and decreased p-GSK3β levels in the hippocampus. These results are the first to show an in vivo neuroprotective role of (D-Ser2)Oxm in APP/PS1 mice, and this role involves the improvement of synaptic plasticity, clearance of Aβ and normalization of PI3K/AKT/GSK3β cell signaling in the hippocampus. This study suggests that (D-Ser2)Oxm holds promise for the prevention and treatment of AD. •We evaluated the neuroprotective actions of (D-Ser2) Oxm in a transgenic AD mouse model.•(D-Ser2) Oxm alleviated the impairments of working memory and long-term spatial memory in APP/PS1 mice.•(D-Ser2) Oxm reduced the number of Aβ plaques in the hippocampus of APP/PS1 mice.•(D-Ser2) Oxm reversed the suppression of hippocampal long-term potentiation in the APP/PS1 mice.•The neuroprotective role of (D-Ser2) Oxm may involve the maintenance of PI3K/AKT/GSK3β homeostasis.
ISSN:0018-506X
1095-6867
DOI:10.1016/j.yhbeh.2019.104640